Where to Inject Tirzepatide: Complete Injection Site Guide

Key Takeaways

• You can inject tirzepatide in your abdomen or your thigh, or another person can inject it in the back of your upper arm.
• Your body absorbs about the same amount whichever of these sites you use, so pick the one that's comfortable and easy for you.
• Use a new spot with each dose. Pick two or three spots to switch between, so it's easy to remember.
• Follow the instructions that come with your medicine, and ask your provider or pharmacist about anything that's unclear.

You may feel nervous about your first few injections. After that, it mostly comes down to remembering where you injected last time.

Where Can You Inject Tirzepatide?

Just under the skin of your abdomen or thigh, or the back of your upper arm if someone else gives the injection, as the Zepbound instructions describe. If you're injecting on your own, your abdomen and thighs give you plenty of room to rotate.

Does the Site Change How Well It Works?

Your body absorbs about the same amount whichever of these sites you use, so the choice is yours.

The Zepbound label reports similar levels in the blood after injections in the abdomen, thigh or upper arm.

So pick the site you can reach easily, the one that feels most comfortable, and the one you're least likely to skip.

Start with an evaluation

How to Rotate Your Injection Sites

The label asks you to rotate injection sites with each dose, and it's an easy habit to build.

Pick two or three spots, such as the left and right sides of your abdomen, and rotate between them. Just remember which one you used last. Some people notice redness, itching, bruising or pain where they inject, and the label lists these among injection site reactions.

Simple Habits for Every Dose

• Keep your pen to yourself. Never share a pen, even with a new needle, because sharing can pass on blood-borne infections.
• Use a fresh needle. For vials, the label says to use a new syringe and needle for each injection.
• Keep insulin separate. If you also use insulin, the tirzepatide label for type 2 diabetes asks for separate injections that are never mixed. The same body region is fine, as long as the two aren't right next to each other.

Side Effects and Safety Notes

The most common side effects listed on the Zepbound label are stomach-related: nausea, diarrhea, vomiting, constipation, abdominal pain and indigestion.

Tirzepatide isn't right for everyone. Your provider will ask about:

• Thyroid history: a personal or family history of medullary thyroid cancer or MEN 2.
• Past conditions: pancreatitis, gallbladder disease or kidney problems.
• Other medicines: especially diabetes medicines that can lower blood sugar.
• Allergies: any serious allergic reaction to a medicine.

Contact your provider promptly about severe or lasting stomach pain, ongoing vomiting or anything at an injection site that concerns you. Check with them before changing your dose, schedule or site plan.

Your Next Step

Wondering how much to inject rather than where? The dosing guide explains how to read the measurements on your prescription, and how Zepbound works walks through what it does for hunger. If you haven't started yet, your plan begins with an evaluation, where a licensed provider reviews your health history and goals.

Frequently Asked Questions

Can I inject tirzepatide in my arm?

Yes, with help. The Zepbound label names the back of the upper arm as a site another person injects, alongside the abdomen and thigh for injecting on your own. Follow the instructions for the medicine you're prescribed.

Does injecting in the stomach work better than the thigh?

Your body absorbs about the same amount either way. The Zepbound label reports similar levels from the abdomen, thigh and upper arm. Pick the spot you can reach comfortably and reliably.

How often should I change injection sites?

With each dose. Switching between two or three spots keeps it simple. In the Zepbound weight-reduction trials, injection site reactions such as redness, itching, bruising, pain or rash were reported by 6% to 8% of people taking Zepbound, compared with 2% on placebo.

Can I share a pen with my partner?

No. The Zepbound label says never to share a pen between people, even if the needle is changed, because sharing can pass on blood-borne infections. Each person needs their own.

Why do some guides say I can inject my own upper arm?

They may be describing a different medicine. The Ozempic (semaglutide) label lists the abdomen, thigh or upper arm without the condition that another person gives an upper-arm injection. Follow the directions for the medicine in your hand.

Which instructions do I follow for a compounded prescription?

Follow the instructions supplied with your prescription and your pharmacy label. Compounded medicines aren't FDA-approved, and the FDA doesn't review their safety, effectiveness or quality before they're marketed. A compounded preparation has no labeling of its own, so the brand-label directions above don't replace the directions for your compounded prescription. Ask your provider or pharmacist about anything that's unclear.

What does the boxed warning on Zepbound say?

The Zepbound label carries a boxed warning about thyroid C-cell tumors. Tirzepatide caused these tumors in rats; it isn't known whether it does in people. Zepbound isn't for anyone with a personal or family history of medullary thyroid cancer or MEN 2, or a serious allergy to tirzepatide.

The label also says Zepbound isn't recommended for severe gastroparesis, and to tell your care team before any procedure with anesthesia or deep sedation. It notes that routine blood tests (calcitonin) or thyroid ultrasound are of uncertain value for catching these tumors early, so tell your provider about a lump in your neck, trouble swallowing, shortness of breath or hoarseness that doesn't go away. A compounded preparation has no reviewed labeling, so it carries no boxed warning of its own, which isn't the same as no risk.

References

Eli Lilly and Company. (2026). Zepbound (tirzepatide) injection, for subcutaneous use: Prescribing information (revised 4/2026), Boxed Warning, Dosage and Administration, Contraindications, Warnings and Precautions, Adverse Reactions and Clinical Pharmacology. DailyMed, U.S. National Library of Medicine. Read 2026-08-20. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b

Eli Lilly and Company. (2026). Mounjaro (tirzepatide) injection, for subcutaneous use: Prescribing information (revised 4/2026), Dosage and Administration. DailyMed, U.S. National Library of Medicine. Read 2026-08-20. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0

Novo Nordisk Pharmaceutical Industries, LP. (2026). Ozempic (semaglutide) injection, for subcutaneous use: Prescribing information (revised 5/2026), Dosage and Administration. DailyMed, U.S. National Library of Medicine. Read 2026-08-20. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79

U.S. Food and Drug Administration. (2026). Compounding and the FDA: Questions and answers. Read 2026-08-20. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers